The Current Role of Vasodilatory Beta-1 Blockers for Hypertension Management – Novel Mechanisms of Action, Hemodynamic Effects, Cardiometabolic Profiles and Clinical Efficacy Across the Cardiovascular Risk Spectrum
L. Michael
Prisant, MD, FACP, FACC, FAHA